New breast cancer therapies
available p38 MAPK inhibitors Breast tumors
different breast cancer subtypes
clinic new therapies
triple negative tumors
Hormonal therapies
human tumors
PDX of specific breast cancer subtypes
breast tumor size
new drug combination therapy
p38 MAPK inhibition
Luminal B
combination of surgery
potential therapeutic use
patients
Trastuzumab
use of patient
hormonal therapy
anti-Her2 receptor antibody
main molecular subtypes
preclinical validation
preclinical models
potential benefit
chemotherapeutic drugs
tumor cell biology
chemotherapeutic agent cisplatin
effective diagnostic tools
pharmacological evidence
improved treatments
derived xenografts
complexity
recent work
basic knowledge
heterogeneity
grading systems
radiotherapy
chemotherapy
results
malignancy
urgent need
idea
clinical trials